Neuland Laboratories Ltd

NSE: NEULANDLAB · BSE: 524558 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹21,880.00
Market cap: ₹28,072 Cr
Revenue (annual): ₹2,023 Cr
Net profit (annual): ₹364.0 Cr
P/E (TTM): 56.4×Sector 47.4×
Promoter holding: 32.62%-0.01% QoQ
FII holding: 21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

7 Sep 2026 17:25 IST BSE

Neuland Laboratories Capacity Expansion: ₹126 Cr Investment

Neuland Laboratories' board approved ₹126 Crore capex to acquire 134 acres of land in Andhra Pradesh for future expansion. The company holds ROFR on additional land.

Value: ₹126.0 Cr
land acquisition: 134.0 acres

Read the filing ↗

5 Aug 2026 16:47 IST BSE

Capacity Expansion

Neuland Laboratories Capacity Expansion: ₹39.8 Cr Investment

Neuland Laboratories Ltd announced a capacity expansion of 18 KL at an investment of ₹39.80 Crore. This expansion aims to meet growing customer demand.

Value: ₹39.80 Cr
Execution: 6 - 7 Months

Read the filing ↗